[Primary chronic myelofibrosis in the Japanese population].
Okamura
Takashi
T
Shimoda
Kazuya
K
D000818:Animals; D018952:Antigens, CD34; D044466:Asian People; D002869:Chromosome Aberrations; D002908:Chronic Disease; D016207:Cytokines; D003613:Danazol / Q000627:therapeutic use; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D007564:Japan; D009389:Neovascularization, Pathologic; D055728:Primary Myelofibrosis / Q000145:classification / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D011379:Prognosis; D012720:Severity of Illness Index; D015398:Signal Transduction; D013156:Splenectomy
D018952:Antigens, CD34; D016207:Cytokines; D016898:Interferon-alpha; D003613:Danazol